基于工程化下游转录因子的 CD19 CAR-T 细胞活化调控
Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor.
16.0分
★☆☆☆☆
站内排序·非疗效
FRONTIER PAPERS
Regulation of CD19 CAR-T cell activation based on an engineered downstream transcription factor.
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer.
Physiological lentiviral vectors for the generation of improved CAR-T cells.
A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。